Hydroxy estolides, poly-capped estolides, and methods of making the same

US9410103B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9410103-B2
Application numberUS-201414454538-A
CountryUS
Kind codeB2
Filing dateAug 7, 2014
Priority dateAug 31, 2011
Publication dateAug 9, 2016
Grant dateAug 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are poly-capped estolides, including those of the Formula IV in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 2; R 1 is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R 3 and R 4 , independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. Hydroxy estolides are also described herein, which may be suitable end products, or serve as intermediates to provide poly-capped estolides. Also provided are compositions containing poly-capped estolides and methods of making both said poly-capped estolides and compositions thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. At least one compound according to Formula VI: wherein z is an integer selected from 7 and 8; p is 0; q is 0; R 5 and R 6 are independently selected from —C(O)R 1 and an unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched; R 1 is an unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched; and R 2 is selected from unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched, and a substituent represented by Formula II: wherein x is, independently for each occurrence, an integer selected from 0 to 20; y is, independently for each occurrence, an integer selected from 0 to 20; n is 0 to 20; R 3 is selected from hydrogen and unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched; W 1 , W 2 , W 3 , W 4 , W 5 , W 6 , and W 7 , independently for each occurrence, are selected from —CH 2 — and —CH═CH—; and Q 1 , Q 2 , and Q 3 , independently for each occurrence, are selected from hydrogen and —CH 3 , wherein each fatty acid chain residue of said at least one compound is unsubstituted. 2. The at least one compound according to claim 1 , wherein R 5 and R 6 are independently selected from —C(O)R 1 . 3. The at least one compound according to claim 2 , wherein R 1 , independently for each occurrence, is selected from an unsubstituted C 1 to C 18 alkyl that is saturated or unsaturated, and branched or unbranched. 4. The at least one compound according to claim 2 , wherein R 1 , independently for each occurrence, is selected from C 5 to C 11 alkyl. 5. The at least one compound according to claim 3 , wherein R 1 is saturated and unbranched for each occurrence. 6. The at least one compound according to claim 1 , wherein R 5 and R 6 are independently selected from C 1 -C 10 alkyl. 7. The at least one compound according to claim 1 , wherein W 3 , W 5 , and W 7 for each occurrence are —CH 2 —. 8. The at least one compound according to claim 7 , wherein W 4 and W 6 for each occurrence are —CH 2 —. 9. The at least one compound according to claim 1 , wherein z is 7. 10. The at least one compound according to claim 1 , wherein R 2 is a substituent represented by Formula II: 11. The at least one compound according to claim 10 , wherein R 3 is selected from optionally substituted C 1 to C 20 alkyl that is saturated or unsaturated and branched or unbranched. 12. The at least one compound according to claim 1 , wherein Q 1 is hydrogen. 13. The at least one compound according to claim 1 , wherein W 3 is —CH 2 — for each occurrence. 14. The at least one compound according to claim 1 , wherein z is 8. 15. The at least one compound according to claim 1 , wherein R 2 is an unsubstituted C 1 -C 18 alkyl that is saturated or unsaturated, and branched or unbranched. 16. The at least one compound according to claim 15 , wherein R 2 is saturated. 17. The at least one compound according to claim 16 , wherein R 2 is an unsubstituted C 6 to C 12 alkyl that is branched. 18. The at least one compound according to claim 13 , wherein R 2 is an unsubstituted C 1 -C 18 alkyl that is saturated or unsaturated, and branched or unbranched. 19. The at least one compound according to claim 18 , wherein Q 1 is hydrogen.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9410103B2 cover?
Provided herein are poly-capped estolides, including those of the Formula IV in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 2; R 1 is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R 2 is selected from hydrogen and optionally substituted alkyl that is saturated o…
Who is the assignee on this patent?
Biosynthetic Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C10M105/42. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).